Edmonton, Canada

R Rao Koganty

USPTO Granted Patents = 7 


Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 1991-2013

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: R Rao Koganty: Innovator in Vaccine Development

Introduction

R Rao Koganty is a prominent inventor based in Edmonton, Canada, known for his significant contributions to the field of immunology. With a total of seven patents to his name, Koganty has made remarkable strides in vaccine development, particularly in modulating immune responses.

Latest Patents

Among his latest innovations is a vaccine designed for modulating between T1 and T2 immune responses. This invention provides liposomal vaccines containing immunogenic lipopeptides that are capable of modulating the humoral and cellular immune responses in vivo. This groundbreaking work has the potential to enhance vaccine efficacy and improve patient outcomes.

Career Highlights

Throughout his career, Koganty has worked with notable companies such as Oncothyreon Inc. and Biomira, Inc. His experience in these organizations has allowed him to refine his expertise in vaccine technology and immunotherapy.

Collaborations

Koganty has collaborated with esteemed colleagues, including Wladyslaw A Budzynski and Mark J Krantz. These partnerships have fostered a collaborative environment that has led to innovative solutions in the field of immunology.

Conclusion

R Rao Koganty stands out as a key figure in vaccine innovation, with a focus on enhancing immune response modulation. His contributions continue to shape the future of immunotherapy and vaccine development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…